Vasopressors for the treatment of septic shock: Systematic review and meta-analysis.
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: International guidelines recommend dopamine or norepinephrine as first-line vasopressor agents in septic shock. Phenylephrine, epinephrine, vasopressin and terlipressin are considered second-line agents. Our objective was to assess the evidence for the efficiency and safety of all vasopressors in septic shock. METHODS: Systematic review and meta-analysis. We searched electronic database of MEDLINE, CENTRAL, LILACS and conference proceedings up to June 2014. We included randomized controlled trials comparing different vasopressors for the treatment of adult patients with septic shock. Primary outcome was all-cause mortality. Other clinical and hemodynamic measurements were extracted as secondary outcomes. Risk ratios (RR) and mean differences with 95% confidence intervals (CI) were pooled. RESULTS: Thirty-two trials (3,544 patients) were included. Compared to dopamine (866 patients, 450 events), norepinephrine (832 patients, 376 events) was associated with decreased all-cause mortality, RR 0.89 (95% CI 0.81-0.98), corresponding to an absolute risk reduction of 11% and number needed to treat of 9. Norepinephrine was associated with lower risk for major adverse events and cardiac arrhythmias compared to dopamine. No other mortality benefit was demonstrated for the comparisons of norepinephrine to epinephrine, phenylephrine and vasopressin / terlipressin. Hemodynamic data were similar between the different vasopressors, with some advantage for norepinephrine in central venous pressure, urinary output and blood lactate levels. CONCLUSIONS: Evidence suggests a survival benefit, better hemodynamic profile and reduced adverse events rate for norepinephrine over dopamine. Norepinephrine should be regarded as the first line vasopressor in the treatment of septic shock.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In the absence of septic shock or fungemia, some implanted tunneled catheter infections may be treated effectively with prolonged antimicrobial therapy if removal of the catheter is not practical (273).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [273]
Experimental — accuracy not yet measuredIn the citing paper
“In a systematic review and meta-analysis of 11 RCTs, norepinephrine resulted in a lower mortality (RR 0.89; 95% CI 0.81–0.98) and lower risk of arrhythmias (RR 0.48; 95% CI 0.40–0.58) compared with dopamine [347].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [347]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Early goal-directed therapy in the treatment of severe sepsis and septic shock
Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E., & Tomlanovich, M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010307 · Cited by 10,743 · cited 1×
“5 ml/kg/hr within 6 hours of initiation of therapy [5].”
BackgroundEstimating the mean and variance from the median, range, and the size of a sample
Hozo, S. P., Djulbegovic, B., & Hozo, I. (2005) · BMC Medical Research Methodology · doi:10.1186/1471-2288-5-13 · Cited by 9,062
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503 · cited 1×
“Septic shock accounts for about 9% of admissions, and is the most common cause of death in intensive care units (ICUs) [1,2].”
BackgroundSurviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea-Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2210-z · Cited by 3,321
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea-Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000117317.18092.e4 · Cited by 3,018 · cited 2×
“The Surviving Sepsis Campaign recommends norepinephrine or dopamine as the first-choice vasopressor agent followed by epinephrine in patients who respond poorly to dopamine or norepinephrine [7,8].”
BackgroundA randomized trial of protocol-based care for early septic shock.
The ProCESS Investigators (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401602 · Cited by 2,414 · cited 6×
“The concept of early goal directed therapy was challenged recently in a large RCT [43], in which no mortality benefit with protocol based resuscitation was observed compared with usual care.”
BackgroundInfluentialComparison of Dopamine and Norepinephrine in the Treatment of Shock
De Backer, D., Biston, P., Devriendt, J., Madl, C., Chochrad, D., Aldecoa, C., Brasseur, A., Defrance, P., Gottignies, P., & Vincent, J.-L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907118 · Cited by 1,940 · cited 5×
“triple blinded [15], 8 trials were double blinded [13, 24, 26, 27, 30–32, 36], 2 were single blinded [20, 34] and the others were open-labeled or not stated.”
BackgroundResultInfluentialVasopressin versus Norepinephrine Infusion in Patients with Septic Shock
Russell, J. A., Walley, K. R., Singer, J., Gordon, A. C., Hébert, P. C., Cooper, D. J., Holmes, C. L., Mehta, S., Granton, J. T., Storms, M. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa067373 · Cited by 1,924 · cited 1×
“Study ID Sequence generation Allocation concealment Blinding Ethical committee / informed consent ITT analysis of primary outcome Incomplete data reporting Valid definition of septic shock Agrawal 2011 [11] Unclear Unclear Open Yes / Yes Yes Unclear Yes Albanese 2005 [12] Low Unclear Open Yes / Yes Yes Unclear Yes Ann…”
Dellinger, R. P. (2004) · Critical Care Medicine · Cited by 1,848
Beneficial Effects of Short-term Vasopressin Infusion during Severe Septic Shock
Patel, B. M., Chittock, D. R., Russell, J. A., & Walley, K. R. (2002) · Anesthesiology · doi:10.1097/00000542-200203000-00011 · Cited by 680 · cited 1×
“Study ID Sequence generation Allocation concealment Blinding Ethical committee / informed consent ITT analysis of primary outcome Incomplete data reporting Valid definition of septic shock Agrawal 2011 [11] Unclear Unclear Open Yes / Yes Yes Unclear Yes Albanese 2005 [12] Low Unclear Open Yes / Yes Yes Unclear Yes Ann…”
Current Epidemiology of Septic Shock: The CUB-Réa Network
Annane, D., Aegerter, P., Jars-Guincestre, M. C., & Guidet, B. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2201087 · Cited by 637 · cited 2×
“Septic shock accounts for about 9% of admissions, and is the most common cause of death in intensive care units (ICUs) [1,2].”
BackgroundHas the mortality of septic shock changed with time?
Friedman, G., Silva, E., & Vincent, J.-L. (1998) · Critical Care Medicine · doi:10.1097/00003246-199812000-00045 · Cited by 607 · cited 1×
“The mortality rate reported is 40 to 60% [1,3].”
BackgroundAnnane, D., Vignon, P., Renault, A., Bollaert, P.-E., Charpentier, C., Martin, C., Troché, G., Ricard, J.-D., Nitenberg, G., Papazian, L., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61344-0 · Cited by 567 · cited 1×
“Study ID Sequence generation Allocation concealment Blinding Ethical committee / informed consent ITT analysis of primary outcome Incomplete data reporting Valid definition of septic shock Agrawal 2011 [11] Unclear Unclear Open Yes / Yes Yes Unclear Yes Albanese 2005 [12] Low Unclear Open Yes / Yes Yes Unclear Yes Ann…”
Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update
Hollenberg, S. M., Ahrens, T. S., Annane, D., Astiz, M. E., Chalfin, D. B., Dasta, J. F., Heard, S. O., Martin, C., Napolitano, L. M., Susla, G. M., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000139761.05492.d6 · Cited by 521 · cited 1×
“The Surviving Sepsis Campaign recommends norepinephrine or dopamine as the first-choice vasopressor agent followed by epinephrine in patients who respond poorly to dopamine or norepinephrine [7,8].”
BackgroundNorepinephrine or Dopamine for the Treatment of Hyperdynamic Septic Shock?
Martin, C., Papazian, L., Perrin, G., Saux, P., & Gouin, F. (1993) · Chest · doi:10.1378/chest.103.6.1826 · Cited by 460
Levy, B., Bollaert, P.-E., Charpentier, C., Nace, L., Audibert, G., Bauer, P., Nabet, P., & Larcan, A. (1997) · Intensive Care Medicine · doi:10.1007/s001340050329 · Cited by 444 · cited 1×
“Study ID Sequence generation Allocation concealment Blinding Ethical committee / informed consent ITT analysis of primary outcome Incomplete data reporting Valid definition of septic shock Agrawal 2011 [11] Unclear Unclear Open Yes / Yes Yes Unclear Yes Albanese 2005 [12] Low Unclear Open Yes / Yes Yes Unclear Yes Ann…”
Circulating vasopressin levels in septic shock
Sharshar, T., Blanchard, A., Paillard, M., Raphael, J. C., Gajdos, P., & Annane, D. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000063046.82359.4a · Cited by 413 · cited 1×
“One of the rationales for the use of non-adrenergic vasopressors is relative vasopressin deficiency in patients with septic shock [44] and the hypothesis that vasopressin can reduce the need for catecholamines and AEs associated with adrenergic stimulation.”
BackgroundMarik, P. E. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03520170064037 · Cited by 401 · cited 1×
“Study ID Sequence generation Allocation concealment Blinding Ethical committee / informed consent ITT analysis of primary outcome Incomplete data reporting Valid definition of septic shock Agrawal 2011 [11] Unclear Unclear Open Yes / Yes Yes Unclear Yes Albanese 2005 [12] Low Unclear Open Yes / Yes Yes Unclear Yes Ann…”
Arnold, R. C., Shapiro, N. I., Jones, A. E., Schorr, C., Pope, J., Casner, E., Parrillo, J. E., Dellinger, R. P., & Trzeciak, S. (2009) · Shock · doi:10.1097/shk.0b013e3181971d47 · Cited by 400 · cited 5×
“Later the concept of lactate clearance was added to the goals as an alternative or addition to the ScvO2 [6].”
BackgroundInfluentialLow-Dose Vasopressin in the Treatment of Vasodilatory Septic Shock
Malay, M. B., Ashton, R. C., Landry, D. W., & Townsend, R. N. (1999) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/00005373-199910000-00014 · Cited by 391 · cited 2×
“One trial compared vasopressin to placebo [24]; Additional open-label vasopressors could be added to both study arms equally in 16/32 trials (Fig 2).”
BackgroundDopamine versus norepinephrine in the treatment of septic shock: A meta-analysis*
De Backer, D., Aldecoa, C., Njimi, H., & Vincent, J.-L. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e31823778ee · Cited by 389 · cited 1×
“Another review [46], focused only on the comparison of norepinephrine and dopamine in septic shock, but included observational studies as well as randomized controlled trials.”
BackgroundDe Backer, D., Creteur, J., Silva, E., & Vincent, J.-L. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000063045.77339.b6 · Cited by 371 · cited 1×
“Study ID Sequence generation Allocation concealment Blinding Ethical committee / informed consent ITT analysis of primary outcome Incomplete data reporting Valid definition of septic shock Agrawal 2011 [11] Unclear Unclear Open Yes / Yes Yes Unclear Yes Albanese 2005 [12] Low Unclear Open Yes / Yes Yes Unclear Yes Ann…”
A comparison of epinephrine and norepinephrine in critically ill patients
Myburgh, J. A., Higgins, A., Jovanovska, A., Lipman, J., Ramakrishnan, N., Santamaria, J., & the CAT Study investigators (2008) · Intensive Care Medicine · doi:10.1007/s00134-008-1219-0 · Cited by 368 · cited 1×
“Study ID Sequence generation Allocation concealment Blinding Ethical committee / informed consent ITT analysis of primary outcome Incomplete data reporting Valid definition of septic shock Agrawal 2011 [11] Unclear Unclear Open Yes / Yes Yes Unclear Yes Albanese 2005 [12] Low Unclear Open Yes / Yes Yes Unclear Yes Ann…”
Regional blood flow and oxygen transport in septic shock
BUOKONEN, E., TAKALA, J., KARI, A., SAXÉN, H., MERTSOLA, J., & HANSEN, E. J. J. (1993) · Critical Care Medicine · doi:10.1097/00003246-199309000-00011 · Cited by 360 · cited 1×
“Study ID Sequence generation Allocation concealment Blinding Ethical committee / informed consent ITT analysis of primary outcome Incomplete data reporting Valid definition of septic shock Agrawal 2011 [11] Unclear Unclear Open Yes / Yes Yes Unclear Yes Albanese 2005 [12] Low Unclear Open Yes / Yes Yes Unclear Yes Ann…”
Vasopressors for hypotensive shock
Gamper, G., Havel, C., Arrich, J., Losert, H., Pace, N. L., Müllner, M., & Herkner, H. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003709.pub4 · Cited by 239
Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial
Lauzier, F., Lévy, B., Lamarre, P., & Lesur, O. (2006) · Intensive Care Medicine · doi:10.1007/s00134-006-0378-0 · Cited by 226 · cited 1×
“Study ID Sequence generation Allocation concealment Blinding Ethical committee / informed consent ITT analysis of primary outcome Incomplete data reporting Valid definition of septic shock Agrawal 2011 [11] Unclear Unclear Open Yes / Yes Yes Unclear Yes Albanese 2005 [12] Low Unclear Open Yes / Yes Yes Unclear Yes Ann…”
Morelli, A., Ertmer, C., Rehberg, S., Lange, M., Orecchioni, A., Cecchini, V., Bachetoni, A., D'Alessandro, M., Van Aken, H., Pietropaoli, P., et al. (2009) · Critical Care · doi:10.1186/cc7990 · Cited by 221 · cited 1×
“Study ID Sequence generation Allocation concealment Blinding Ethical committee / informed consent ITT analysis of primary outcome Incomplete data reporting Valid definition of septic shock Agrawal 2011 [11] Unclear Unclear Open Yes / Yes Yes Unclear Yes Albanese 2005 [12] Low Unclear Open Yes / Yes Yes Unclear Yes Ann…”
Terlipressin or norepinephrine in hyperdynamic septic shock: A prospective, randomized study*
Albanèse, J., Leone, M., Delmas, A., & Martin, C. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000178182.37639.d6 · Cited by 212
Duranteau, J., Sitbon, P., Teboul, J. L., Vicaut, E., Anguel, N., Richard, C., & Samii, K. (1999) · Critical Care Medicine · doi:10.1097/00003246-199905000-00021 · Cited by 173 · cited 1×
“Study ID Sequence generation Allocation concealment Blinding Ethical committee / informed consent ITT analysis of primary outcome Incomplete data reporting Valid definition of septic shock Agrawal 2011 [11] Unclear Unclear Open Yes / Yes Yes Unclear Yes Albanese 2005 [12] Low Unclear Open Yes / Yes Yes Unclear Yes Ann…”
Morelli, A., Ertmer, C., Rehberg, S., Lange, M., Orecchioni, A., Laderchi, A., Bachetoni, A., D'Alessandro, M., Van Aken, H., Pietropaoli, P., et al. (2008) · Critical Care · doi:10.1186/cc7121 · Cited by 163 · cited 1×
“Study ID Sequence generation Allocation concealment Blinding Ethical committee / informed consent ITT analysis of primary outcome Incomplete data reporting Valid definition of septic shock Agrawal 2011 [11] Unclear Unclear Open Yes / Yes Yes Unclear Yes Albanese 2005 [12] Low Unclear Open Yes / Yes Yes Unclear Yes Ann…”
Effect of Dopamine vs Norepinephrine on Hemodynamics in Septic Shock
Schreuder, W. O., Schneider, A. J., Groeneveld, A. B. J., & THIJS, L. G. (1989) · CHEST Journal · doi:10.1378/chest.95.6.1282 · Cited by 155
EFFICACY AND SAFETY OF DOPAMINE VERSUS NOREPINEPHRINE IN THE MANAGEMENT OF SEPTIC SHOCK
Patel, G. P., Grahe, J. S., Sperry, M., Singla, S., Elpern, E., Lateef, O., & Balk, R. A. (2010) · Shock · doi:10.1097/shk.0b013e3181c6ba6f · Cited by 144 · cited 2×
“Study ID Sequence generation Allocation concealment Blinding Ethical committee / informed consent ITT analysis of primary outcome Incomplete data reporting Valid definition of septic shock Agrawal 2011 [11] Unclear Unclear Open Yes / Yes Yes Unclear Yes Albanese 2005 [12] Low Unclear Open Yes / Yes Yes Unclear Yes Ann…”
BackgroundNorepinephrine or Dopamine for Septic Shock: Systematic Review of Randomized Clinical Trials
Vasu, T. S., Cavallazzi, R., Hirani, A., Kaplan, G., Leiby, B., & Marik, P. E. (2012) · Journal of Intensive Care Medicine · doi:10.1177/0885066610396312 · Cited by 108
Seguin, P. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.122471 · Cited by 79 · cited 1×
“Study ID Sequence generation Allocation concealment Blinding Ethical committee / informed consent ITT analysis of primary outcome Incomplete data reporting Valid definition of septic shock Agrawal 2011 [11] Unclear Unclear Open Yes / Yes Yes Unclear Yes Albanese 2005 [12] Low Unclear Open Yes / Yes Yes Unclear Yes Ann…”
Vasopressors for hypotensive shock
Havel, C., Arrich, J., Losert, H., Gamper, G., Müllner, M., & Herkner, H. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003709.pub3 · Cited by 77
Guerin, J.-P., Levraut, J., Samat-Long, C., Leverve, X. M., Grimaud, D., & Ichaï, C. (2004) · Shock · doi:10.1097/01.shk.0000150549.45338.6c · Cited by 69 · cited 1×
“Study ID Sequence generation Allocation concealment Blinding Ethical committee / informed consent ITT analysis of primary outcome Incomplete data reporting Valid definition of septic shock Agrawal 2011 [11] Unclear Unclear Open Yes / Yes Yes Unclear Yes Albanese 2005 [12] Low Unclear Open Yes / Yes Yes Unclear Yes Ann…”
Morelli, A., Donati, A., Ertmer, C., Rehberg, S., Kampmeier, T., Orecchioni, A., Di Russo, A., D'Egidio, A., Landoni, G., Lombrano, M. R., et al. (2011) · Critical Care · doi:10.1186/cc10453 · Cited by 53 · cited 1×
“Study ID Sequence generation Allocation concealment Blinding Ethical committee / informed consent ITT analysis of primary outcome Incomplete data reporting Valid definition of septic shock Agrawal 2011 [11] Unclear Unclear Open Yes / Yes Yes Unclear Yes Albanese 2005 [12] Low Unclear Open Yes / Yes Yes Unclear Yes Ann…”
Zhou, S., Qiu, H., Huang, Y., Yang, Y., & Zheng, R. (2002) · PubMed · Cited by 52
Comparison of phenylephrine and norepinephrine in the management of dopamine-resistant septic shock
Singh, D. K., & Jain, G. (2010) · Indian Journal of Critical Care Medicine · doi:10.4103/0972-5229.63033 · Cited by 38 · cited 2×
“Study ID Sequence generation Allocation concealment Blinding Ethical committee / informed consent ITT analysis of primary outcome Incomplete data reporting Valid definition of septic shock Agrawal 2011 [11] Unclear Unclear Open Yes / Yes Yes Unclear Yes Albanese 2005 [12] Low Unclear Open Yes / Yes Yes Unclear Yes Ann…”
BackgroundTerlipressin in the treatment of late phase catecholamine-resistant septic shock.
Svoboda, P., Scheer, P., Kantorová, I., Doubek, J., Dudra, J., Radvan, M., & Radvanová, J. (2012) · PubMed · doi:10.5754/hge10550 · Cited by 37 · cited 2×
“Industrial sponsorship was stated in one trial [39].”
BackgroundMethodChakraborty, A., Mathur, S. K., & Dhunna*, R. (2007) · Indian Journal of Critical Care Medicine · doi:10.4103/0972-5229.37713 · Cited by 22 · cited 1×
“Study ID Sequence generation Allocation concealment Blinding Ethical committee / informed consent ITT analysis of primary outcome Incomplete data reporting Valid definition of septic shock Agrawal 2011 [11] Unclear Unclear Open Yes / Yes Yes Unclear Yes Albanese 2005 [12] Low Unclear Open Yes / Yes Yes Unclear Yes Ann…”
Comparative study of dopamine and norepinephrine in the management of septic shock
Agrawal, A., Gupta, A., Consul, S., & Shastri, P. S. (2011) · Saudi Journal of Anaesthesia · doi:10.4103/1658-354x.82784 · Cited by 17 · cited 1×
“Study ID Sequence generation Allocation concealment Blinding Ethical committee / informed consent ITT analysis of primary outcome Incomplete data reporting Valid definition of septic shock Agrawal 2011 [11] Unclear Unclear Open Yes / Yes Yes Unclear Yes Albanese 2005 [12] Low Unclear Open Yes / Yes Yes Unclear Yes Ann…”
Yuchu, Z. (2010) · Clinical Education of General Practice · Cited by 4
[Use of vasopressin to correct hemodynamic disorders in patients with abdominal sepsis].
Ll, P. (2007) · PubMed · Cited by 3
Wu, J., Chen, J., Ou, Y.-B., Yang, C., Chen, M., & Huang, S. (2010) · Chin Arch Gen Surg(Electronic Edition) · doi:10.3877/cma.j.issn.1674-0793.2010.02.008 · Cited by 2
Research works printed but not linked: 3
- Chen H, Zeng Z (2012) Comparisom of the effect and complication between dopaimne and norepinephrine on treatment of the septic shock. Jiangxi Medical Journal 47: 565– 567.
- High K (2008) Impact of Dopamine and norepinephrine on renal perfusion in patients with septic shock. Journal of Hebei Medicine 30: 1188– 1121.
- Zhuangyu Y (2011) Affect of norepinephrine and dopamine on infectious tissue oxygen metabolism and hemodynamics in patients with shock. Shandong Medicine Journal 51: 93– 94.
Cited by
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
“However, a recent systematic review and meta-analysis that included 11 randomized trials (n =1,710) comparing norepinephrine to dopamine does not support the routine use of dopamine in the management of septic shock (264).”
BackgroundSurviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Weiss, S. L., Peters, M. J., Alhazzani, W., Agus, M. S. D., Flori, H. R., Inwald, D. P., Nadel, S., Schlapbach, L. J., Tasker, R. C., Argent, A. C., et al. (2020) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000002198 · Cited by 1,228
Metadata
- Authors
- Avni, T., Lador, A., Lev, S., Leibovici, L., Paul, M., & Grossman, A.
- Affiliations
- Tel Aviv University (IL)
- Technion – Israel Institute of Technology (IL)
- Corresponding author
- Avni, Tomer
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-08-03
- Volume
- 10
- Issue
- 8
- Pages
- e0129305
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4523170
- OpenAlex
- W1630391490
- Cited by
- 293
- References
- 48
- Citations by year
- 2026: 19 · 2025: 24 · 2024: 33 · 2023: 26 · 2022: 29 · 2021: 37 · 2020: 30 · 2019: 34 · 2018: 29 · 2017: 17 · 2016: 11 · 2015: 3
- FWCI
- 2.60
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
- Health Sciences › Medicine › Surgery › Abdominal Surgery and Complications
- Keywords
- septic shock, vasopressors, norepinephrine, dopamine, phenylephrine, epinephrine, vasopressin, terlipressin, all-cause mortality, hemodynamic outcomes, cardiac arrhythmias, blood lactate
- MeSH terms
- Terlipressin, Epinephrine, Hemodynamics, Humans, Lypressin, Norepinephrine, Phenylephrine, Shock, Septic, Vasoconstrictor Agents, Vasopressins, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.